Title	Publication Date	Language	Citations
Targeted Agents for HER2-Positive Breast Cancer: Optimal Use in Older Patients	2021/08/23	English
Prescribed Doses of CYP2D6-Metabolized Drugs and Hemodynamic Responses in Relation to CYP2D6 Genotype Among Older Patients Exposed to Polypharmacy	2020/04/29	English
Acknowledgement to Referees	2021/11/22	English
Acknowledgement to Referees	2020/11/18	English
Verteporfin	2000/02/01	English
Risedronate	1998/01/01	English
Propionyl-L-Carnitine	1998/01/01	English
Acknowledgement	2003/01/01	English
Diclofenac/Hyaluronic Acid	1999/01/01	English
Repaglinide	1998/01/01	English
Valrubicin	1999/01/01	English
Transdermal Oxybutynin	2003/01/01	English
Propionyl-L-Carnitine	1998/01/01	English
Verteporfin	2000/02/01	English
Extended-Release Oxybutynin	2000/02/01	English
Darifenacin	2004/01/01	English
Risedronate	1998/01/01	English
Extended-Release Oxybutynin	2000/02/01	English
The Authors Reply	2003/01/01	English
Valrubicin	1999/01/01	English
Diclofenac/Hyaluronic Acid	1999/01/01	English
Raloxifene	1998/01/01	English
Vardenafil	2002/01/01	English
Raloxifene	1998/01/01	English
Unoprostone (Isopropyl Unoprostone)	1996/01/01	English
Acknowledgement	2011/12/01	English
Clinical Inertia Remains a Problem	2011/12/01	English
Authors’ Reply to Pergolizzi: “Treatment of Chronic Pain in Older People: Evidence-Based Choice of Strong-Acting Opioids”	2012/11/13	English
Authors’ Reply to Reeve and Wiese: “Difficulties Reducing Inappropriate Prescribing of Proton Pump Inhibitors in the Elderly”	2012/11/01	English
Acknowledgement	2012/11/14	English